Summary & Overview
CPT 0572U: Telomere Length FISH Test for Prostate Cancer Risk
CPT code 0572U designates a proprietary laboratory analysis (PLA) for ProsTAV®, a specific telomere-length test from Life Length S.L. The assay measures cellular telomere length using fluorescence in situ hybridization (FISH) on a blood sample and applies a diagnostic algorithm to report a prostate cancer risk level. As a PLA code, 0572U is unique to a single manufacturer's test and identifies a distinct molecular diagnostic service in claims and reimbursement workflows.
Nationally, PLA codes matter because they signal manufacturer-specific tests with discrete clinical claims handling and price transparency implications. This review addresses major payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare to summarize how the code is recognized across commercial and federal programs.
Readers will learn the clinical scope and service setting for 0572U, the role of the test in prostate cancer risk assessment, and the payer landscape covered in the analysis. The publication also summarizes available benchmarks, relevant policy or coverage considerations, and practical coding and billing context for submitting claims for this proprietary laboratory test. Data not available in the input for specific coverage decisions, reimbursement rates, or associated ICD-10 codes is noted where applicable.
Billing Code Overview
CPT code 0572U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to a single, manufacturer-specific laboratory test: ProsTAV® from Life Length S.L. The test uses a blood sample and measures telomere length in cells using fluorescence in situ hybridization (FISH). Results are processed by a diagnostic algorithm and reported as a risk level for prostate cancer.
Service type: Proprietary laboratory diagnostic test (telomere length analysis with algorithmic risk reporting)
Typical site of service: Clinical laboratory or independent diagnostic testing facility (blood draw performed in an outpatient clinic or phlebotomy site, analysis performed in the sending laboratory)
Clinical & Coding Specifications
Clinical Context
A typical patient is a man aged 50–75 with elevated prostate-specific antigen (PSA) levels, prior atypical prostate biopsy, or other clinical concern for prostate cancer seeking additional risk stratification. The clinician orders the ProsTAV® telomere-length assay (0572U) as an adjunctive laboratory test to refine prostate cancer risk assessment. A phlebotomy appointment is scheduled at an outpatient laboratory or an ambulatory infusion/diagnostic center. A blood sample is collected, labeled with the patient and order identifiers, and shipped per the manufacturer's instructions to Life Length S.L. or its designated laboratory. The laboratory performs fluorescence in situ hybridization (FISH) on peripheral blood cells to measure telomere length, analyzes data using the proprietary diagnostic algorithm, and reports a risk level for prostate cancer (e.g., low, intermediate, high). Results are transmitted to the ordering urologist or primary care clinician who incorporates the assay result into shared decision-making about further diagnostic steps (repeat biopsy, MRI, active surveillance, or definitive therapy). Typical sites of service include outpatient laboratory draw stations, ambulatory surgical centers for patients already undergoing urologic workup, and physician offices with phlebotomy services. Common modifiers for billing include 22 (increased procedural services), 52 (reduced services), and 53 (discontinued procedure).
Coding Specifications
| Modifier | Description | When to Use |
|---|